Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.
about
Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated DonorsThe Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis.Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank.Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platformsAllogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survivalHigh-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.Concise review: umbilical cord blood transplantation: past, present, and futurePre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host diseaseCord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion.Immune Reactions following Cord Blood Transplantations in Adults.Allogeneic hematopoietic stem cell transplantation.Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results.Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries.Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.Umbilical cord blood grafts for hematopoietic transplantation in adults: a cup half empty or half full?The Role of HLA in Cord Blood Transplantation.Adult umbilical cord blood transplantation: a comprehensive review.Cord blood transplantation for adults.Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche.Expanding the role of umbilical cord blood transplantation.Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.Reduced-intensity conditioning and umbilical cord blood transplantation in adults.Cord blood transplantation in adults.History of cord blood transplantation.Cord Blood Transplantation: Can We Make it Better?The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression.Umbilical cord blood transplant for malignancies: a hope or hype.Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.Results of the cord blood transplantation (COBLT) study unrelated donor banking program.Early infections in adult patients undergoing unrelated donor cord blood transplantation.Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH).Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes.Risk factors and options to improve engraftment in unrelated cord blood transplantationAllogeneic cord blood transplantation in children with hematological malignancies: a long-term follow-up single-center study.Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005.Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years.
P2860
Q28066500-45B5BC51-3068-465A-AD4C-107D58DDE517Q33445489-F32F6B79-B76C-41B6-B933-3E6888758AF6Q33449843-5EC6EC55-E84F-4D9A-A242-17080D8C7905Q33705051-DED9A2DA-C39F-47B1-A19A-7AB7551505F1Q33816659-69D5BA0F-3E31-463B-A0C5-32EDBA1FA0E3Q34470409-EDF293B9-A48C-4DC4-9CCC-2E6972B2997CQ34601968-3B0BC736-10F9-4DE9-9CE3-0AFE8B3EDA38Q34985679-F4A569D8-51A2-40A5-9743-D273E9E7EEE3Q34986499-BE30C369-7879-41B5-B7C1-036CFA1D7E2FQ35054475-81572B31-B2E0-43F3-9129-44EEB787D9FBQ35201902-2CE3D0B7-1E2D-4A77-B455-EB5017DEEE9BQ35674530-D24D39B3-D54E-4F3C-B814-7150DC976D4CQ35850703-5721F2E6-53AB-4630-A70E-347405CAEBDDQ36004664-3FD30352-9795-465F-9ED4-509C8F0FB550Q36059652-F1E825DE-55D6-4664-8455-A6416F34D3D4Q36150943-AAC0906C-E6EF-4A37-B7D2-F6852AF9ADA1Q36336608-E82A63E4-F41B-4FDA-A069-2AAA92F86399Q36496725-21F84720-9CD3-4603-BAFF-BA846FA302EEQ36588337-E7A7429D-B37D-40DD-9D55-63E392EB0B90Q36681962-66E0CD34-C036-4D2D-AC1C-6A921E25F64BQ36759585-210A1390-916E-49F6-9E1A-163CA324C506Q37207777-35462A1D-5010-4609-B2DD-3CCAA4F1B9D3Q37607984-9ABFE7B8-6CBC-496B-A540-33B1A8918B58Q37607986-CB30ECE7-F5A6-4C56-AADB-971EF51BB692Q37607988-8FDDE7F8-A1F8-4271-AC45-C91213838B0AQ38142167-4C6D9E33-289E-48FF-942A-71808EE25E61Q38163428-548B1E78-A90E-4571-91DB-92E7B63BBA20Q39421621-77DE5246-C9C0-43C2-BA45-8C133E3DA54BQ40311559-C3FD0769-6BC5-457E-BB47-5C2D77F91FEAQ40351661-6AE70B63-548F-49E5-99E1-2F11C534FAA1Q40416657-3278B908-10D6-4663-9562-7198CE4A0490Q40416663-B7E4D8C0-D9CF-4938-8F22-19569173D9FCQ40569370-FCBB8943-F1F4-41B8-80DB-D31211DD8B45Q41478754-FF9B6E8D-F4C9-4593-82F5-251545E3A406Q41688144-674BF8DD-8552-44CA-9AFB-F003B46D4A16Q41877676-DDF7D9E3-B969-4415-ACDB-885C27333B6FQ42735351-5D94D786-F914-4B78-9521-8DBC19DAA8A8Q43602281-6689D32F-A6CF-415E-B8C7-3D7A16191BEBQ43730176-BDEEC124-6545-45DB-BAF2-B7BE987697BCQ44718475-DB2A1F9B-1030-4A0E-B61C-6F8B66D598A0
P2860
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Standardized, unrelated donor ...... with hematologic malignancies.
@en
Standardized, unrelated donor ...... with hematologic malignancies.
@nl
type
label
Standardized, unrelated donor ...... with hematologic malignancies.
@en
Standardized, unrelated donor ...... with hematologic malignancies.
@nl
prefLabel
Standardized, unrelated donor ...... with hematologic malignancies.
@en
Standardized, unrelated donor ...... with hematologic malignancies.
@nl
P2093
P356
P1433
P1476
Standardized, unrelated donor ...... with hematologic malignancies.
@en
P2093
Barragán E
Benlloch L
P304
P356
10.1182/BLOOD.V98.8.2332
P407
P577
2001-10-01T00:00:00Z